ACS DOBFAR SPA FDA Approval ANDA 208790

ANDA 208790

ACS DOBFAR SPA

FDA Drug Application

Application #208790

Documents

Letter2018-05-10

Application Sponsors

ANDA 208790ACS DOBFAR SPA

Marketing Status

Prescription001

Application Products

001INJECTABLE;INTRAMUSCULAR, INTRAVENOUSEQ 1GM BASE/VIAL0ERTAPENEM SODIUMERTAPENEM SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2018-04-16STANDARD
LABELING; LabelingSUPPL2AP2020-08-21STANDARD
LABELING; LabelingSUPPL5AP2022-08-25STANDARD
LABELING; LabelingSUPPL7AP2022-08-25STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null7
SUPPL5Null7
SUPPL7Null7

TE Codes

001PrescriptionAP

CDER Filings

ACS DOBFAR SPA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 208790
            [companyName] => ACS DOBFAR SPA
            [docInserts] => ["",""]
            [products] => [{"drugName":"ERTAPENEM SODIUM","activeIngredients":"ERTAPENEM SODIUM","strength":"EQ 1GM BASE\/VIAL","dosageForm":"INJECTABLE;INTRAMUSCULAR, INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/16\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2018\\\/208790Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"08\/21\/2020","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"08\/21\/2020","submission":"SUPPL-1","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-08-21
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.